ESC 365 - Diabetes: how to reduce risk from a cardiovascular perspective?

EAPC Premium Access

Diabetes: how to reduce risk from a cardiovascular perspective?

Session: Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Topic: Diabetes and the Heart

Speaker: Professor D. Grobbee (Utrecht, NL)

Sponsored by PACE-CME: Physicians' Academy for Cardiovascular Education, supported with an educational grant by Novo Nordisk.

Event: EuroPrevent 2018

Congress Presentation

Add to my library

About the speaker

Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))

40 presentations

11 followers

4 more presentations in this session

Introduction - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Speaker: Professor D. Grobbee (Utrecht, NL)

The cardiovascular challenge for primary care in diabetes.

Speaker: Professor R. Hobbs (Oxford, GB)

Practical management of cardiovascular risk: lessons from latest diabetes trials.

Speaker: Professor L. Ryden (Stockholm, SE)

Discussion - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Speaker: Professor D. Grobbee (Utrecht, NL) Professor R. Hobbs (Oxford, GB) Professor L. Ryden (Stockholm, SE)

Access the full session

Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.

Speakers: Professor D. Grobbee, Professor D. Grobbee, Professor R. Hobbs, Professor L. Ryden, Professor D. Grobbee...

About the event

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources